Anavex Life Sciences (AVXL) Proxy filing summary

Executive summary

• Annual Meeting of Stockholders scheduled for September 24, 2026, with a reminder sent to shareholders.

• Shareholders are urged to vote for all six board nominees using the WHITE proxy card to protect investment value.

• Forward-looking statements address company strategies, director nominations, and business prospects, with caution regarding risks and uncertainties.

Voting matters and shareholder proposals

• Six nominees are proposed for election to the board: Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Mr. Gautam Patel, Dr. Adrian Senderowicz, and Dr. Claus van der Velden.

• Shareholders are advised to disregard proxy materials from PVG Asset Management.

Board of directors and corporate governance

• Information about directors and executive officers, including their interests and security holdings, is disclosed in the proxy and referenced SEC filings.